EleonoraGLadMD
Ophthalmology • Durham, NCRetinal Disease
Associate Professor of Ophthalmology, Duke University Medical Center
Dr. Lad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
121 Crimson Oak Dr
Durham, NC 27713Phone+1 650-796-8526Fax+1 919-660-5070
Education & Training
Duke University Medical CenterFellowship, 2011 - 2012
Stanford Health Care-Sponsored Stanford UniversityResidency, Ophthalmology, 2008 - 2011
Kaiser Permanente Northern California (Oakland)Internship, Internal Medicine, 2007 - 2008
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2007
Certifications & Licensure
CA State Medical License 2008 - Present
NC State Medical License 2011 - 2025
VA State Medical License 2011 - 2012- American Board of Ophthalmology Ophthalmology
- American Board of OphthalmologyBoard Certification
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 2 citationsLIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera...David Boyer, Allen Hu, David Warrow, Samantha Xavier, Victor Gonzalez
Retina. 2024-03-01 - 1 citationsContactless, autonomous robotic alignment of optical coherence tomography for in vivo evaluation of diseased retinas.Ryan McNabb, Pablo Ortiz, Kyung-Min Roh, Ailin Song, Mark Draelos
Research Square. 2023-01-09 - 8 citationsMachine learning OCT predictors of progression from intermediate age-related macular degeneration to geographic atrophy and vision loss.Eleonora Lad, Karim Sleiman, David L Banks, Sanjay Hariharan, Traci Clemons
Ophthalmology Science. 2022-06-01
Press Mentions
Photobiomodulation for Early Dry AMD Gets Enthusiastic ReceptionJuly 23rd, 2024- Apellis’ Syfovre Approved as First Treatment for Geographic Atrophy Despite Uncertain Clinical BenefitMarch 7th, 2023
- New FDA-Approved Drug Can Slow Vision Loss for Those with Age-Related Eye DiseaseFebruary 27th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
